eISSN: 2081-2841
ISSN: 1689-832X
Journal of Contemporary Brachytherapy
Current Issue Archive Supplements Articles in Press Journal Information Aims and Scope Editorial Office Editorial Board Register as Author Register as Reviewer Instructions for Authors Abstracting and indexing Subscription Advertising Information Links
SCImago Journal & Country Rank

vol. 10
Case report

Image-guided high-dose-rate intracavitary brachytherapy technique for nasal keloid – a case report

Cheng Huang, Mingyuan He, Hongfu Zhao, Guanghui Cheng

J Contemp Brachytherapy 2018; 10, 3: 279–282
Online publish date: 2018/06/29
View full text
Get citation
JabRef, Mendeley
Papers, Reference Manager, RefWorks, Zotero
The aim of this study is to report an uncommon case of nasal keloid treated with adaptive image-guided high-dose-rate (HDR) intracavitary brachytherapy. A 34-year-old female presented with nasal keloid after facial trauma was treated with scar resection and HDR intracavitary brachytherapy with a customized eccentric applicator. The total dose was 21 Gy in 6 fractions. During 3 years of follow-up, there was no evidence of recurrence at the local site, and no complications. In conclusion, HDR intracavitary brachytherapy is an effective way to prevent the recurrence of nasal keloids post-surgery.

brachytherapy, customized applicator, nasal keloid

Garg MK, Weiss P, Sharma AK et al. Adjuvant high dose rate brachytherapy (Ir-192) in the management of keloids which have recurred after surgical excision and external radiation. Radiother Oncol 2004; 73: 233-236.
Jie S, Xin L, Sun Y et al. Hypofractionated electron-beam radiation therapy for keloids: retrospective study of 568 cases with 834 lesions. J Radiat Res 2015; 56: 811-817.
Ashcroft KJ, Syed F, Bayat A. Site-specific keloid fibroblasts alter the behavior of normal skin and normal scar fibroblasts through paracrine signaling. PLoS One 2013; 8: e75600.
Nast A, Eming S, Fluhr J et al. German S2k guidelines for the therapy of pathological scars (hypertrophic scars and keloids). J Dtsch Dermatol Ges 2012; 10: 747-762.
Flickinger JC. A  radiobiological analysis of multicenter data for postoperative keloid radiotherapy. Int J Radiat Oncol Biol Phys 2011; 79: 1164-1170.
Ogawa R. The most current algorithms for the treatment and prevention of hypertrophic scars and keloids. Plast Reconstr Surg 2010; 125: 557-568.
Shen J, Lian X, Sun Y et al. Hypofractionated electron-beam radiation therapy for keloids: retrospective study of 568 cases with 834 lesions. J Radiat Res 2015; 56: 811-817.
Kal HB, Veen RE. Biologically effective doses of postoperative radiotherapy in the prevention of keloids. Dose-effect relationship. Strahlenther Onkol 2005; 181: 717-723.
Guix B, Henríquez I, Andrés A  et al. Treatment of keloids by high-dose-rate brachytherapy: A  seven-year study. Int J Radiat Oncol Biol Phys 2001; 50: 167-172.
Mankowski P, Kanevsky J, Tomlinson J et al. Optimizing radio­ therapy for keloids: a  meta-analysis systematic review com­ paring recurrence rates between different radiation moda­ lities. Ann Plast Surg 2017; 78: 403-411.
Vivante H, Salgueiro MJ, Ughetti R et al. 32P-patch contact brachyradiotherapy in the management of recalcitrant keloids and hypertrophic scars. Indian J Dermatol Venereol Leprol 2007; 73: 336-339.
Ahmad M, Ahmad H, Khattak MR et al. Postoperative single versus multiple fractions high-dose rate iridium-192 surface mould brachytherapy for keloid treatment: a  comparative study. J Radiother Pract 2018; 17: 60-65.
De Cicco L, Vischioni B, Vavassori A  et al. Postoperative management of keloids: Low-dose-rate and high-dose-rate bra­ chytherapy. Brachytherapy 2014; 13: 508-513.
Guinot JL, Rembielak A, Perez-Calatayud J et al. GEC-ESTRO ACROP recommendations in skin brachytherapy. Radiother Oncol 2018; 126: 377-385.
Sakamoto T, Oya N, Shibuya K et al. Dose-response relationship and dose optimization in radiotherapy of postoperative keloids. Radiother Oncol 2009; 91: 271-276.
Viani GA, Stefano EJ, Afonso SL et al. Postoperative strontium-90 brachytherapy in the prevention of keloids: results and prognostic factors. Int J Radiat Oncol Biol Phys 2009; 73: 1510-1516.
Quick links
© 2019 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe